SGLT2 Inhibitors Market Size, Share & Trends Analysis Report By Drug (Canagliflozin, Dapagliflozin, Empagliflozin, Ertugliflozin, Ipragliflozin, Sotagliflozin, Others), By Indication (Type 2 Diabetes, Cardiovascular, Chronic Kidney Disease, Weight Management, Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034
Last Updated: December 23, 2025 |
Author: Debashree B |
Format: |
Report Code: SRPH57974DR |
Pages: 110